Purchases and Sales Made in Q4 2021 in Taysha Gene Therapies, Inc. (TSHA)
This table provides information about the institutional ownership of Taysha Gene Therapies, Inc. (TSHA) during Q4 2021. The information is specifically focused on institutions that hold shares of Taysha Gene Therapies, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2022
Q4 2021
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-361- 1.79% |
$4.13K - $6.93K
|
19.8K
$34.8K
|
|
|
Feb 11, 2022
Q4 2021
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-1.34K- 60.77% |
$15.4K - $25.8K
|
867
$1.53K
|
|
|
Feb 11, 2022
Q4 2021
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-1.68K- 0.13% |
$19.2K - $32.2K
|
1.31M
$2.3M
|
|
|
Feb 07, 2022
Q4 2021
|
Sg Americas Securities, LLC
|
SELL
|
- |
-9.17KClosed |
$105K - $176K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Gilder Gagnon Howe & CO LLC
New York, NY |
SELL
|
- |
-37.6KClosed |
$430K - $721K
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Granite Point Capital Management, L.P.
|
SELL
|
- |
-40KClosed |
$457K - $768K
|
0
$0
|
|
|
Feb 10, 2022
Q4 2021
|
Davenport & CO LLC
|
SELL
|
- |
-55.1K- 66.57% |
$630K - $1.06M
|
27.7K
$48.7K
|
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-183K- 43.49% |
$2.09M - $3.51M
|
238K
$418K
|
|
|
Feb 14, 2022
Q4 2021
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-320KClosed |
$3.66M - $6.15M
|
0
$0
|